DK1345594T3 - Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin - Google Patents
Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradinInfo
- Publication number
- DK1345594T3 DK1345594T3 DK01989654T DK01989654T DK1345594T3 DK 1345594 T3 DK1345594 T3 DK 1345594T3 DK 01989654 T DK01989654 T DK 01989654T DK 01989654 T DK01989654 T DK 01989654T DK 1345594 T3 DK1345594 T3 DK 1345594T3
- Authority
- DK
- Denmark
- Prior art keywords
- ivabradine
- pharmaceutical composition
- controlled release
- solid pharmaceutical
- thermoforming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0017015A FR2818552B1 (fr) | 2000-12-26 | 2000-12-26 | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
PCT/FR2001/004134 WO2002051387A1 (fr) | 2000-12-26 | 2001-12-21 | Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1345594T3 true DK1345594T3 (da) | 2007-05-21 |
Family
ID=8858190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01989654T DK1345594T3 (da) | 2000-12-26 | 2001-12-21 | Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040028743A1 (zh) |
EP (1) | EP1345594B1 (zh) |
JP (2) | JP2004518665A (zh) |
KR (1) | KR100542472B1 (zh) |
CN (1) | CN1203844C (zh) |
AT (1) | ATE352290T1 (zh) |
AU (1) | AU2002228119B2 (zh) |
BR (1) | BR0116548A (zh) |
CA (1) | CA2432645A1 (zh) |
CY (1) | CY1106390T1 (zh) |
CZ (1) | CZ304587B6 (zh) |
DE (1) | DE60126332T2 (zh) |
DK (1) | DK1345594T3 (zh) |
EA (1) | EA005814B1 (zh) |
ES (1) | ES2280420T3 (zh) |
FR (1) | FR2818552B1 (zh) |
HK (1) | HK1060514A1 (zh) |
HU (1) | HU229410B1 (zh) |
MX (1) | MXPA03005840A (zh) |
NO (1) | NO333776B1 (zh) |
NZ (1) | NZ526406A (zh) |
PL (1) | PL203835B1 (zh) |
PT (1) | PT1345594E (zh) |
SI (1) | SI1345594T1 (zh) |
SK (1) | SK286413B6 (zh) |
WO (1) | WO2002051387A1 (zh) |
ZA (1) | ZA200304441B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
FR2834896B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'ivabradine |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
US20060165790A1 (en) * | 2003-06-27 | 2006-07-27 | Malcolm Walden | Multiparticulates |
GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
FR2882556B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882553B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
WO2010128525A2 (en) * | 2009-05-04 | 2010-11-11 | Dinesh Shantilal Patel | A formulation of ivabradine for treating the cardiovascular disease |
PL2579859T3 (pl) | 2010-06-14 | 2015-12-31 | Ratiopharm Gmbh | Kompozycja stała zawierająca iwabradynę |
CN101897682B (zh) * | 2010-07-13 | 2012-02-15 | 石药集团欧意药业有限公司 | 一种伊伐布雷定或其可药用盐固体制剂及其制备方法 |
CN102908327B (zh) * | 2011-08-05 | 2015-03-11 | 江苏恒瑞医药股份有限公司 | 伊伐布雷定或其可药用盐的缓释制剂 |
WO2015091992A1 (en) * | 2013-12-20 | 2015-06-25 | Synthon B.V. | Pharmaceutical composition comprising amorphous ivabradine |
EP3025705B8 (en) | 2014-11-25 | 2018-11-28 | Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi | Stable ivabradine formulations |
CN104398486B (zh) * | 2014-12-08 | 2018-01-12 | 武汉武药科技有限公司 | 一种盐酸伊伐布雷定渗透泵控释片及其制备方法 |
EP3366282A1 (en) | 2017-02-28 | 2018-08-29 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral pharmaceutical compositions of ivabradine |
KR20190001340A (ko) * | 2017-06-27 | 2019-01-04 | 에리슨제약(주) | 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
DE4138513A1 (de) * | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
CA2231050A1 (en) * | 1995-09-07 | 1997-03-13 | Biovail International Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
AU725811B2 (en) * | 1997-08-26 | 2000-10-19 | Aventisub Llc | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
DE19901040A1 (de) * | 1999-01-14 | 2000-07-20 | Knoll Ag | Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe |
FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
-
2000
- 2000-12-26 FR FR0017015A patent/FR2818552B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-21 SI SI200130697T patent/SI1345594T1/sl unknown
- 2001-12-21 AT AT01989654T patent/ATE352290T1/de active
- 2001-12-21 PT PT01989654T patent/PT1345594E/pt unknown
- 2001-12-21 JP JP2002552533A patent/JP2004518665A/ja active Pending
- 2001-12-21 DK DK01989654T patent/DK1345594T3/da active
- 2001-12-21 BR BR0116548-8A patent/BR0116548A/pt not_active Application Discontinuation
- 2001-12-21 CA CA002432645A patent/CA2432645A1/fr not_active Withdrawn
- 2001-12-21 KR KR1020037008654A patent/KR100542472B1/ko not_active IP Right Cessation
- 2001-12-21 CZ CZ2003-2020A patent/CZ304587B6/cs not_active IP Right Cessation
- 2001-12-21 WO PCT/FR2001/004134 patent/WO2002051387A1/fr active IP Right Grant
- 2001-12-21 HU HU0302522A patent/HU229410B1/hu not_active IP Right Cessation
- 2001-12-21 AU AU2002228119A patent/AU2002228119B2/en not_active Ceased
- 2001-12-21 DE DE60126332T patent/DE60126332T2/de not_active Expired - Lifetime
- 2001-12-21 ES ES01989654T patent/ES2280420T3/es not_active Expired - Lifetime
- 2001-12-21 EP EP01989654A patent/EP1345594B1/fr not_active Expired - Lifetime
- 2001-12-21 SK SK942-2003A patent/SK286413B6/sk not_active IP Right Cessation
- 2001-12-21 PL PL361662A patent/PL203835B1/pl unknown
- 2001-12-21 CN CNB018213677A patent/CN1203844C/zh not_active Expired - Fee Related
- 2001-12-21 US US10/451,903 patent/US20040028743A1/en not_active Abandoned
- 2001-12-21 MX MXPA03005840A patent/MXPA03005840A/es active IP Right Grant
- 2001-12-21 NZ NZ526406A patent/NZ526406A/en not_active IP Right Cessation
- 2001-12-21 EA EA200300667A patent/EA005814B1/ru not_active IP Right Cessation
-
2003
- 2003-06-06 ZA ZA200304441A patent/ZA200304441B/en unknown
- 2003-06-16 NO NO20032737A patent/NO333776B1/no not_active IP Right Cessation
-
2004
- 2004-05-17 HK HK04103476A patent/HK1060514A1/xx not_active IP Right Cessation
-
2007
- 2007-03-16 CY CY20071100370T patent/CY1106390T1/el unknown
-
2009
- 2009-12-25 JP JP2009295406A patent/JP2010100641A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000584A3 (ru) | Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием | |
DK1345594T3 (da) | Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin | |
TW200730200A (en) | Method for the preparation of a wet granulated drug product | |
DK1066049T3 (da) | Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse | |
BR9916835A (pt) | Composição de galantamina de liberação controlada | |
DK1861073T3 (da) | Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed | |
HRP20090194T1 (en) | Dry granulated composition comprising emtricitabine and tenofovir df | |
AU3652102A (en) | Compounds and their uses | |
NO20013060L (no) | Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff | |
DK1210384T3 (da) | Uorganisk belægningssammensætning, en fremgangsmåde til fremstilling af denne samt anvendelse deraf | |
SE0004053D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
EA200201149A1 (ru) | Фармацевтические композиции и способы для предотвращения рецидива мигрени | |
EA200300664A1 (ru) | Твердая термоформируемая фармацевтическая композиция для контролируемого высвобождения периндоприла | |
WO2001022943A8 (en) | A slow release pharmaceutical composition comprising a magnesium oxychloride cement | |
AR032049A1 (es) | Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina | |
NO20052480D0 (no) | Utvidede farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer. | |
PT1499278E (pt) | Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa | |
BR0212254A (pt) | Composição farmaceutica | |
MXPA02012456A (es) | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis. | |
AU2001295836A1 (en) | Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis | |
DE50211461D1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum | |
DK1144382T3 (da) | Fremgangsmåde til fremstilling af 3-substituerede 1,5-diarylpyrazoler | |
ECSP003358A (es) | Composiciones de betahistina de liberacion controlada |